Get ‘Responsive,’ Not ‘Defensive’ When US FDA Finds GMP Problems, Consultant Advises

Responses to form 483s, including effectiveness of CAPA plan for each problem, determines whether enforcement door opens or closes, says Teresa Gorecki of Compliance Architects. “I see companies sitting at that point … the organization either moves into a defensive mode or responsive mode.”